Drug compliance of children and adolescents with epilepsy

Ali Akbar Asadi-Pooya1

  • 1Shiraz University of Medical Sciences, Department of Pediatrics, Nemazee Hospital, Shiraz, Fars 71937-11351, Iran. asadipoa@sums.ac.ir

Seizure
|June 28, 2005
PubMed

Insights

Drug compliance in pediatric epilepsy is satisfactory in over 70% of cases. Factors like maternal age and family size influence adherence, highlighting the need for targeted education and simplified treatment regimens.

Area of Science:

  • Pediatric Neurology
  • Pharmacology
  • Public Health

Background:

  • Drug compliance is crucial for managing epilepsy in children and adolescents.
  • Understanding factors influencing adherence is vital for effective treatment outcomes.

Purpose of the Study:

  • To determine the drug compliance rate in families with children/adolescents suffering from epilepsy.
  • To identify factors associated with drug compliance in this population.

Main Methods:

  • A six-month study involving interviews with 181 pediatric epilepsy patients and their families at Motahary Clinic, Shiraz.
  • Data collected on patient demographics, epilepsy characteristics, and family factors.

Main Results:

  • Satisfactory drug compliance was observed in 72.4% of patients.
  • Maternal age, family history of epilepsy, and family size significantly impacted compliance.
  • Phenobarbital use was associated with higher compliance rates.
  • Etiology, therapy type, disease duration, patient age, comorbidities, parental smoking, education, and location did not significantly affect compliance.

Conclusions:

  • Nearly three-fourths of pediatric epilepsy patients demonstrated satisfactory drug compliance.
  • Noncompliance was not significantly linked to epilepsy cause, disease duration, socio-economic status, or polytherapy.
  • Enhanced medication education, simplified treatment regimens, and smaller family sizes, particularly with younger mothers, may improve compliance.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...